REFERENCES
1. Roberts EA, Schilsky ML. Current and emerging issues in Wilson’s disease. N Engl J Med. 2023;389:922-38.
2. Calinas F, Cardoso H, Carvalhana S, et al. Practical and multidisciplinary review on Wilson disease: the Portuguese perspective. GE Port J Gastroenterol. 2024:1-17.
3. Wang M, Wang F, Tao Z, Yang W. Analysis of factors affecting early hepatic steatosis in pediatric patients with Wilson’s disease in China: a retrospective study. Medicine (Baltimore). 2025;104:e45501.
4. Najimi Z, Elsaboni L, Mtegha M, et al. Analysis of tissue copper levels as a reliable diagnostic tool in paediatric liver disease. Eur J Pediatr. 2025;185:23.
5. Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease1. Liver Int. 2003;23:139-42.
6. Stenson PD, Mort M, Ball EV, et al. The Human Gene Mutation Database (HGMD®): optimizing its use in a clinical diagnostic or research setting. Hum Genet. 2020;139:1197-207.
7. Rehm HL, Berg JS, Brooks LD, et al. ClinGen - the clinical genome resource. N Engl J Med. 2015;372:2235-42.
8. Zhang SJ, Yang WM, Yang YL, Wang JX, He W. Analysis of clinical phenotype and ATP7B variants characteristics of 337 patients with hepatolenticular degeneration in Anhui province. Zhonghua Yi Xue Za Zhi. 2025;105:1172-6.(in Chinese).
9. Mishra AK, Sen Sarma M, Moirangthem A, Sait H. Nuances in ATP7B Genetic Testing and Interpretation in India. J Clin Exp Hepatol. 2026;16:103205.
10. Xu W, Wang R, Dong Y, Wu Z. Pathogenicity of intronic and synonymous variants of ATP7B in Wilson Disease. J Mol Diagn. 2023;25:57-67.
11. Han M, Yang Z. A rare presentation of Wilson disease with normal levels of serum ceruloplasmin and copper and MODY: A case report. Medicine (Baltimore). 2025;104:e43080.
12. Socha P, Jańczyk W, Zanetto A, et al. EASL-ERN clinical practice guidelines on Wilson’s disease. J Hepatol. 2025;82:690-728.
13. Palumbo CS, Schilsky ML. Clinical practice guidelines in Wilson disease. Ann. Transl. Med. 2019;7 Suppl:S65.
14. Cao H, Chen Y, Fan J. Wilson’s disease: from clinical practice to guidelines. Zhonghua Gan Zang Bing Za Zhi. 2014;22:570-2.
15. Tang S, Hou W, Zheng SJ. Recommendations from the European Association for the study of the liver and the European reference network for rare liver diseases clinical practice guidelines for hepatolenticular degeneration. Zhonghua Gan Zang Bing Za Zhi. 2025;33:988-992. (in Chinese).
16. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol. 2012;56:671-85.
17. Li X, Lu Y, Ling Y, et al. Clinical and molecular characterization of Wilson’s disease in China: identification of 14 novel mutations. BMC Med Genet. 2011;12:6.
18. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405-24.
19. Gargano MA, Matentzoglu N, Coleman B, et al. The Human Phenotype Ontology in 2024: phenotypes around the world. Nucleic Acids Res. 2024;52:D1333-46.
20. Landrum MJ, Lee JM, Benson M, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062-7.
21. Francomano CA. Victor Almon McKusick: in the footsteps of Mendel and Osler. American J of Med Genetics Pt A. 2021;185:3193-201.
22. Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A. OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2015;43:D789-98.
23. Auton A, Abecasis GR, Altshuler DM, et al. ; Writing group. A global reference for human genetic variation. Nature. 2015;526:68-74.
24. Karczewski KJ, Francioli LC, Tiao G, et al. ; Genome Aggregation Database Consortium. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434-43.
25. Phan L, Zhang H, Wang Q, et al. The evolution of dbSNP: 25 years of impact in genomic research. Nucleic Acids Res. 2025;53:D925-31.
26. Niehaus A, Azzariti DR, Harrison SM, et al. A survey assessing adoption of the ACMG-AMP guidelines for interpreting sequence variants and identification of areas for continued improvement. Genet Med. 2019;21:1699-701.
27. Ryan A, Nevitt SJ, Tuohy O, Cook P. ; Cochrane Cystic Fibrosis and Genetic Disorders Group. Biomarkers for diagnosis of Wilson’s disease. Cochrane Database Syst Rev. 2019;2019.
28. Hart RK, Fokkema IFAC, Distefano M, et al. HGVS Nomenclature 2024: improvements to community engagement, usability, and computability. Genome Med. 2024;16:149.
29. Ghosh U, Sen Sarma M, Samanta A. Challenges and dilemmas in pediatric hepatic Wilson’s disease. World J Hepatol. 2023;15:1109-26.
30. Stättermayer AF, Entenmann A, Gschwantler M, Zoller H, Hofer H, Ferenci P. The dilemma to diagnose Wilson disease by genetic testing alone. Eur J Clin Investig. 2019;49:e13147.
31. Møller LB, Horn N, Jeppesen TD, et al. Clinical presentation and mutations in Danish patients with Wilson disease. Eur J Hum Genet. 2011;19:935-41.
32. Couchonnal E, Bouchard S, Sandahl TD, et al. ATP7B variant spectrum in a French pediatric Wilson disease cohort. Eur J Med Genet. 2021;64:104305.
33. Garbuz M, Ovchinnikova E, Ovchinnikova A, et al. Spectrum of pathogenic variants of the ATP7B gene and genotype-phenotype correlation in eastern Eurasian patient cohorts with Wilson’s disease. Biomedicines. 2024;12:2833.
34. Kumar M, Sharma S, Pandey S, et al. The genomic landscape of Wilson disease in a pan India disease cohort and population-scale data. Movement Disord Clin Pract. 2024;12:185-95.
35. Deignan JL, Chung WK, Kearney HM, Monaghan KG, Rehder CW, Chao EC. Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2019;21:1267-70.
36. Zhang Q, Xie X, Li H, Li Y, Huang H. Silent but significant: Functional elucidation of a synonymous ATP7B mutation in Wilson’s disease pedigrees. Front. Genet. 2025;16:1604683.
37. Panzer M, Viveiros A, Schaefer B, et al. Synonymous mutation in adenosine triphosphatase copper‐transporting beta causes enhanced exon skipping in Wilson disease. Hepatol Commun. 2022;6:1611-9.
38. Zhou X, Zhou W, Wang C, et al. A comprehensive analysis and splicing characterization of naturally occurring synonymous variants in the ATP7B gene. Front. Genet. 2021;11:592611.
39. Girardini KN, Olthof AM, Kanadia RN. Introns: the “dark matter” of the eukaryotic genome. Front. Genet. 2023;14:1150212.
40. Collins CJ, Yi F, Dayuha R, et al. Direct measurement of ATP7B peptides is highly effective in the diagnosis of Wilson disease. Gastroenterology. 2021;160:2367-2382.e1.
